2025-04-03 |
2025-04-02 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
20,997
-24.2%
17.73
USD 372,294
|
20,997
-24.2%
|
17.73
|
USD 372,294
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Ciaramella Giuseppe
President
Officer
|
7,434
-3.8%
18.35
USD 136,418
|
7,434
-3.8%
|
18.35
|
USD 136,418
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Cavanagh Bethany J
SVP, Finance and Treasurer
Officer
|
3,015
-6.3%
18.35
USD 55,330
|
3,015
-6.3%
|
18.35
|
USD 55,330
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
5,674
-4.6%
18.35
USD 104,122
|
5,674
-4.6%
|
18.35
|
USD 104,122
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
9,566
-9.9%
18.35
USD 175,542
|
9,566
-9.9%
|
18.35
|
USD 175,542
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
30,663
-3.0%
18.35
USD 562,684
|
30,663
-3.0%
|
18.35
|
USD 562,684
|
|
2025-02-20 |
2025-02-18 |
PS
Planned sale
|
Cavanagh Bethany J
SVP, Finance and Treasurer
Officer
|
6,287
-14.3%
35.00
USD 220,045
|
6,287
-14.3%
|
35.00
|
USD 220,045
|
|
2025-02-19 |
2025-02-14 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
10,000
-8.9%
34.00
USD 340,000
|
10,000
-8.9%
|
34.00
|
USD 340,000
|
|
2025-02-03 |
2025-01-30 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
200
-0.0%
27.28
USD 5,456
|
200
-0.0%
|
27.28
|
USD 5,456
|
|
2025-02-03 |
2025-01-30 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
29,800
-3.2%
26.75
USD 797,028
|
29,800
-3.2%
|
26.75
|
USD 797,028
|
|
2025-01-06 |
2025-01-02 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
1,241
-1.2%
24.68
USD 30,628
|
1,241
-1.2%
|
24.68
|
USD 30,628
|
|
2025-01-06 |
2025-01-02 |
PS
Planned sale
|
Cavanagh Bethany J
SVP, Finance and Treasurer
Officer
|
1,117
-2.5%
24.68
USD 27,568
|
1,117
-2.5%
|
24.68
|
USD 27,568
|
|
2024-11-08 |
2024-11-06 |
PS
Planned sale
|
Ciaramella Giuseppe
President
Officer
|
51,110
-31.9%
26.36
USD 1,347,050
|
51,110
-31.9%
|
26.36
|
USD 1,347,050
|
|
2024-10-16 |
2024-10-14 |
PS
Planned sale
|
Ciaramella Giuseppe
President
Officer
|
51,110
-24.2%
26.27
USD 1,342,752
|
51,110
-24.2%
|
26.27
|
USD 1,342,752
|
|
2024-10-02 |
2024-10-01 |
PS
Planned sale
|
Cavanagh Bethany J
SVP, Finance and Treasurer
Officer
|
289
-0.6%
23.48
USD 6,785
|
289
-0.6%
|
23.48
|
USD 6,785
|
|
2024-10-02 |
2024-10-01 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
385
-0.4%
23.48
USD 9,040
|
385
-0.4%
|
23.48
|
USD 9,040
|
|
2024-10-02 |
2024-09-30 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
60,000
-6.0%
24.60
USD 1,476,024
|
60,000
-6.0%
|
24.60
|
USD 1,476,024
|
|
2024-07-03 |
2024-07-02 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
748
-1.1%
22.95
USD 17,167
|
748
-1.1%
|
22.95
|
USD 17,167
|
|
2024-07-03 |
2024-07-01 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
502
-0.7%
23.76
USD 11,928
|
502
-0.7%
|
23.76
|
USD 11,928
|
|
2024-06-28 |
2024-06-27 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
60,000
-5.7%
24.50
USD 1,470,156
|
60,000
-5.7%
|
24.50
|
USD 1,470,156
|
|
2024-04-03 |
2024-04-02 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
16,530
-19.1%
30.54
USD 504,851
|
16,530
-19.1%
|
30.54
|
USD 504,851
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Ciaramella Giuseppe
President
Officer
|
4,534
-2.6%
32.12
USD 145,632
|
4,534
-2.6%
|
32.12
|
USD 145,632
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
18,102
-1.7%
32.13
USD 581,617
|
18,102
-1.7%
|
32.13
|
USD 581,617
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
3,401
-3.1%
32.12
USD 109,240
|
3,401
-3.1%
|
32.12
|
USD 109,240
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
7,157
-7.6%
32.13
USD 229,954
|
7,157
-7.6%
|
32.13
|
USD 229,954
|
|
2024-04-03 |
2024-04-01 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
5,446
-7.2%
32.12
USD 174,926
|
5,446
-7.2%
|
32.12
|
USD 174,926
|
|
2024-04-01 |
2024-03-28 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
60,000
-5.7%
33.86
USD 2,031,402
|
60,000
-5.7%
|
33.86
|
USD 2,031,402
|
|
2024-02-15 |
2024-02-14 |
S
Sale
|
FMR LLC
See Remark 1
|
45,677
-3.6%
31.34
USD 1,431,517
|
45,677
-3.6%
|
31.34
|
USD 1,431,517
|
|
2024-02-15 |
2024-02-14 |
S
Sale
|
FMR LLC
See Remark 1
|
854,323
-40.0%
30.51
USD 26,065,395
|
854,323
-40.0%
|
30.51
|
USD 26,065,395
|
|
2024-02-15 |
2024-02-13 |
S
Sale
|
FMR LLC
See Remark 1
|
1,155
-0.0%
30.93
USD 35,724
|
1,155
-0.0%
|
30.93
|
USD 35,724
|
|
2024-02-15 |
2024-02-13 |
S
Sale
|
FMR LLC
See Remark 1
|
410
-0.0%
30.28
USD 12,415
|
410
-0.0%
|
30.28
|
USD 12,415
|
|
2024-02-02 |
2024-01-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
60,000
-5.4%
25.33
USD 1,519,800
|
60,000
-5.4%
|
25.33
|
USD 1,519,800
|
|
2024-01-05 |
2024-01-03 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
1,907
-2.3%
26.42
USD 50,383
|
1,907
-2.3%
|
26.42
|
USD 50,383
|
|
2023-11-22 |
2023-11-20 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
5,000
-5.7%
31.00
USD 155,000
|
5,000
-5.7%
|
31.00
|
USD 155,000
|
|
2023-11-22 |
2023-11-20 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
5,000
-5.4%
30.00
USD 150,000
|
5,000
-5.4%
|
30.00
|
USD 150,000
|
|
2023-11-01 |
2023-10-30 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
3,448
-5.0%
18.70
USD 64,478
|
3,448
-5.0%
|
18.70
|
USD 64,478
|
|
2023-10-04 |
2023-10-02 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
388
-0.5%
22.85
USD 8,866
|
388
-0.5%
|
22.85
|
USD 8,866
|
|
2023-07-25 |
2023-07-24 |
PS
Planned sale
|
Ciaramella Giuseppe
President and CSO
Officer
|
1,206
-2.4%
32.01
USD 38,604
|
1,206
-2.4%
|
32.01
|
USD 38,604
|
|
2023-07-25 |
2023-07-21 |
PS
Planned sale
|
Ciaramella Giuseppe
President and CSO
Officer
|
155,324
-76.3%
32.06
USD 4,979,687
|
155,324
-76.3%
|
32.06
|
USD 4,979,687
|
|
2023-08-09 |
2023-07-10 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
391
-0.6%
30.48
USD 11,918
|
391
-0.6%
|
30.48
|
USD 11,918
|
|
2023-04-05 |
2023-04-04 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
1,754
-1.5%
29.09
USD 51,029
|
1,754
-1.5%
|
29.09
|
USD 51,029
|
|
2023-04-05 |
2023-04-04 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
1,161
-1.4%
29.09
USD 33,777
|
1,161
-1.4%
|
29.09
|
USD 33,777
|
|
2023-04-05 |
2023-04-04 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
6,493
-0.6%
29.09
USD 188,904
|
6,493
-0.6%
|
29.09
|
USD 188,904
|
|
2023-04-05 |
2023-04-04 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
1,161
-1.6%
29.09
USD 33,777
|
1,161
-1.6%
|
29.09
|
USD 33,777
|
|
2023-04-05 |
2023-04-04 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
10,493
-13.0%
29.77
USD 312,339
|
10,493
-13.0%
|
29.77
|
USD 312,339
|
|
2023-04-05 |
2023-04-04 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
2,186
-4.4%
29.09
USD 63,598
|
2,186
-4.4%
|
29.09
|
USD 63,598
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
1,918
-1.7%
30.31
USD 58,135
|
1,918
-1.7%
|
30.31
|
USD 58,135
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Bellon Christine
Chief Legal Officer
Officer
|
931
-1.1%
30.31
USD 28,219
|
931
-1.1%
|
30.31
|
USD 28,219
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
5,161
-0.5%
30.31
USD 156,430
|
5,161
-0.5%
|
30.31
|
USD 156,430
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Simon Amy
Chief Medical Officer
Officer
|
4,445
-5.2%
30.31
USD 134,728
|
4,445
-5.2%
|
30.31
|
USD 134,728
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
2,454
-4.7%
30.31
USD 74,381
|
2,454
-4.7%
|
30.31
|
USD 74,381
|
|
2023-01-30 |
2023-01-27 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
36,152
-53.6%
45.08
USD 1,629,747
|
36,152
-53.6%
|
45.08
|
USD 1,629,747
|
|
2023-01-30 |
2023-01-26 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
1,102
-3.4%
45.16
USD 49,763
|
1,102
-3.4%
|
45.16
|
USD 49,763
|
|
2023-01-25 |
2023-01-24 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
14,810
-32.1%
45.01
USD 666,657
|
14,810
-32.1%
|
45.01
|
USD 666,657
|
|
2023-01-25 |
2023-01-23 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
5,426
-14.8%
45.02
USD 244,290
|
5,426
-14.8%
|
45.02
|
USD 244,290
|
|
2023-01-20 |
2023-01-18 |
PS
Planned sale
|
Burrell Terry-Ann
Chief Financial Officer
Officer
|
47,195
-60.1%
45.14
USD 2,130,382
|
47,195
-60.1%
|
45.14
|
USD 2,130,382
|
|
2023-01-05 |
2023-01-03 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
600
-0.6%
39.94
USD 23,964
|
600
-0.6%
|
39.94
|
USD 23,964
|
|
2023-01-05 |
2023-01-03 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
1,900
-1.9%
39.07
USD 74,233
|
1,900
-1.9%
|
39.07
|
USD 74,233
|
|
2023-01-05 |
2023-01-03 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
13,704
-12.2%
37.99
USD 520,615
|
13,704
-12.2%
|
37.99
|
USD 520,615
|
|
2023-01-05 |
2023-01-03 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
37,525
-25.1%
37.14
USD 1,393,679
|
37,525
-25.1%
|
37.14
|
USD 1,393,679
|
|
2022-12-14 |
2022-12-12 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
5,383
-5.6%
43.87
USD 236,152
|
5,383
-5.6%
|
43.87
|
USD 236,152
|
|
2022-12-14 |
2022-12-12 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
13,933
-12.6%
43.15
USD 601,209
|
13,933
-12.6%
|
43.15
|
USD 601,209
|
|
2022-12-14 |
2022-12-12 |
PS
Planned sale
|
Ciaramella Giuseppe
President & CSO
Officer
|
31,699
-22.2%
42.30
USD 1,340,868
|
31,699
-22.2%
|
42.30
|
USD 1,340,868
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
2,188
-2.1%
47.91
USD 104,836
|
2,188
-2.1%
|
47.91
|
USD 104,836
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
8,235
-7.3%
46.91
USD 386,339
|
8,235
-7.3%
|
46.91
|
USD 386,339
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
4,569
-3.9%
46.19
USD 211,034
|
4,569
-3.9%
|
46.19
|
USD 211,034
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
5,008
-4.1%
44.93
USD 224,993
|
5,008
-4.1%
|
44.93
|
USD 224,993
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
2,909
-0.3%
47.89
USD 139,325
|
2,909
-0.3%
|
47.89
|
USD 139,325
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
11,756
-1.1%
46.88
USD 551,137
|
11,756
-1.1%
|
46.88
|
USD 551,137
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
7,768
-0.7%
46.19
USD 358,819
|
7,768
-0.7%
|
46.19
|
USD 358,819
|
|
2022-11-02 |
2022-10-31 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
7,567
-0.7%
44.92
USD 339,944
|
7,567
-0.7%
|
44.92
|
USD 339,944
|
|
2022-09-08 |
2022-09-06 |
S
Sale
|
FMR LLC
See Remark 1
Large shareholder
|
551
-100.0%
54.25
USD 29,892
|
551
-100.0%
|
54.25
|
USD 29,892
|
|
2022-08-08 |
2022-08-05 |
S
Sale
|
FMR LLC
See Remark 1
Large shareholder
|
20,159
-100.0%
60.50
USD 1,219,620
|
20,159
-100.0%
|
60.50
|
USD 1,219,620
|
|
2022-08-08 |
2022-08-05 |
S
Sale
|
FMR LLC
See Remark 1
Large shareholder
|
167
-100.0%
61.00
USD 10,187
|
167
-100.0%
|
61.00
|
USD 10,187
|
|
2022-07-29 |
2022-07-28 |
PS
Planned sale
|
Evans John M.
CEO
Executive Director
|
2,247
-1.8%
67.82
USD 152,383
|
2,247
-1.8%
|
67.82
|
USD 152,383
|
|